HESHAM ELGOUHARI: Open Payments
NPI 1104096726 · DENISON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$13,517 in 55 payments from 8 companies in 2025. Trend: 2023 $13,187 · 2024 $13,558 · 2025 $13,517
Speaker / faculty: $10,810Travel & lodging: $1,692Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 26 | $12,894 |
| ABBVIE INC. | 8 | $160 |
| Madrigal Pharmaceuticals | 7 | $156 |
| Ipsen Biopharmaceuticals, Inc | 5 | $128 |
| Intra-Sana Laboratories | 4 | $85 |
| ORPHALAN INC | 2 | $38 |
| Mirum Pharmaceuticals, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $22 |
Products named: Epclusa, MAVYRET, REZDIFFRA, IQIRVO, RELTONE 200 MG, CUVRIOR, Livmarli, Wegovy.
Industry payments across TX — which companies pay providers there.
